| |
|
|
| Name: |
Avidity Partners Management LP |
| City: |
Dallas |
| State: |
TX |
| Zip: |
75201 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
28 |
|
View All Holdings |
Currently
Viewing:
New Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MRK |
Merck & Co Inc |
12 |
New |
$131.20 |
$66,239,000 |
502,000 |
2.35% |
66,239,000 |
502,000 |
0.02 |
Drug Manufacturers - ... |
|
|
CGON |
CG Oncology, Inc |
14 |
New |
$33.89 |
$63,864,000 |
1,454,765 |
2.27% |
63,864,000 |
1,454,765 |
2.204 |
N/A |
|
|
ILMN |
Illumina Inc |
15 |
New |
$108.10 |
$63,730,000 |
464,100 |
2.27% |
63,730,000 |
464,100 |
0.318 |
Scientific & Technica... |
|
|
ALNY |
Alnylam Pharmaceuticals Inc |
30 |
New |
$153.86 |
$36,316,000 |
243,000 |
1.29% |
36,316,000 |
243,000 |
0.198 |
Biotechnology |
|
|
RGNX |
Regenxbio Inc. |
39 |
New |
$12.21 |
$27,392,000 |
1,300,064 |
0.97% |
27,392,000 |
1,300,064 |
2.955 |
N/A |
|
|
APGE |
Apogee Therapeutics, Inc. |
40 |
New |
$36.37 |
$25,576,000 |
384,893 |
0.91% |
25,576,000 |
384,893 |
0.802 |
N/A |
|
|
JSPR |
Jasper Therapeutics Ord Shs |
44 |
New |
$15.12 |
$22,314,000 |
760,000 |
0.79% |
22,314,000 |
760,000 |
0.748 |
N/A |
|
|
GKOS |
Glaukos Corp |
47 |
New |
$113.39 |
$21,121,000 |
224,000 |
0.75% |
21,121,000 |
224,000 |
0.422 |
N/A |
|
|
VERA |
Vera Therapeutics, Inc. |
53 |
New |
$0.00 |
$16,537,000 |
383,500 |
0.59% |
16,537,000 |
383,500 |
0.906 |
N/A |
|
|
JANX |
Janux Therapeutics, Inc. |
56 |
New |
$0.00 |
$14,467,000 |
384,245 |
0.51% |
14,467,000 |
384,245 |
0.963 |
N/A |
|
|
CYBN |
Cybin Inc |
57 |
New |
$0.27 |
$14,425,000 |
34,884,000 |
0.51% |
14,425,000 |
34,884,000 |
21.996 |
N/A |
|
|
PRME |
Prime Medicine, Inc. |
59 |
New |
$6.28 |
$13,930,000 |
1,990,000 |
0.5% |
13,930,000 |
1,990,000 |
2.047 |
N/A |
|
|
KROS |
Keros Therapeutics, Inc. |
60 |
New |
$0.00 |
$13,882,000 |
209,700 |
0.49% |
13,882,000 |
209,700 |
0.617 |
N/A |
|
|
ATXS |
Astria Therapeutics, Inc |
61 |
New |
$8.99 |
$13,822,000 |
982,000 |
0.49% |
13,822,000 |
982,000 |
1.796 |
N/A |
|
|
IMUX |
Immunic Inc |
64 |
New |
$1.08 |
$11,752,000 |
8,902,972 |
0.42% |
11,752,000 |
8,902,972 |
20.07 |
N/A |
|
|
CYTK |
Cytokinetics Inc |
65 |
New |
$51.94 |
$11,638,000 |
166,000 |
0.41% |
11,638,000 |
166,000 |
0.135 |
Biotechnology |
|
|
RDNT |
Radnet Inc |
66 |
New |
$58.33 |
$11,581,000 |
238,000 |
0.41% |
11,581,000 |
238,000 |
0.351 |
Specialized Health Se... |
|
|
ESTA |
Establishment Labs Holdings... |
67 |
New |
$43.50 |
$11,453,000 |
225,000 |
0.41% |
11,453,000 |
225,000 |
0.96 |
N/A |
|
|
NAMS |
Newamsterdam Pharma Ord Shs |
68 |
New |
$0.00 |
$11,234,000 |
475,000 |
0.4% |
11,234,000 |
475,000 |
0.582 |
N/A |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
69 |
New |
$14.87 |
$10,881,000 |
588,500 |
0.39% |
10,881,000 |
588,500 |
0.366 |
Biotechnology |
|
|
AZN |
AstraZeneca Plc (ADR) |
70 |
New |
$78.42 |
$10,840,000 |
160,000 |
0.39% |
10,840,000 |
160,000 |
0.006 |
Drug Manufacturers - ... |
|
|
IONS |
Ionis Pharmaceuticals Inc |
72 |
New |
$40.64 |
$5,636,000 |
130,000 |
0.2% |
5,636,000 |
130,000 |
0.091 |
Drug Manufacturers - ... |
|
|
KYTX |
Kyverna Therapeutics |
74 |
New |
$7.44 |
$5,026,000 |
202,333 |
0.18% |
5,026,000 |
202,333 |
0.471 |
N/A |
|
|
EBS |
Emergent Biosolutions Inc. |
75 |
New |
$6.06 |
$4,827,000 |
1,908,000 |
0.17% |
4,827,000 |
1,908,000 |
3.56 |
Biotechnology |
|
|
DNA |
Ginkgo Bioworks Holdings, Inc |
79 |
New |
$0.42 |
$3,480,000 |
3,000,000 |
0.12% |
3,480,000 |
3,000,000 |
0.226 |
N/A |
|
|
XFOR |
X4 Pharmaceuticals Inc |
80 |
New |
$0.97 |
$3,354,000 |
2,413,000 |
0.12% |
3,354,000 |
2,413,000 |
1.442 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
81 |
New |
$8.50 |
$2,995,000 |
445,706 |
0.11% |
2,995,000 |
445,706 |
0.47 |
N/A |
|
|
KOD |
Kodiak Sciences Inc. |
84 |
New |
$2.61 |
$1,578,000 |
300,000 |
0.06% |
1,578,000 |
300,000 |
0.67 |
N/A |
|
